Gain Therapeutics, Inc.GANXNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank33
3Y CAGR+9.3%
5Y CAGR-29.3%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+9.3%/yr
Annual compound
5Y CAGR
-29.3%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.05 | -2.4% |
| 2023 | 0.06 | +4.4% |
| 2022 | 0.05 | +28.2% |
| 2021 | 0.04 | -68.6% |
| 2020 | 0.13 | -56.8% |
| 2019 | 0.30 | -81.1% |
| 2018 | 1.61 | - |